Miral, Junielyn H.
HRN: 23-03-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2025
AMPICILLIN 1GM (VIAL)
12/15/2025
12/16/2025
IV
2gram
Q6
G2P1 (1001) PU 41 2/7 Weeks
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes